- Reaction score
- 1,298
Australia's medical regulator has approved the use of psychedelics to treat some mental health conditions, making the country one of the first in the world to "officially recognise MDMA and psilocybin as medicines".
International studies looking at psychedelics' ability to treat mental health conditions have shown promising results, however experts have urged caution and called for more research into their long-term effects before making them a mainstream treatment.
From July 1, authorised psychiatrists will be allowed to prescribe MDMA — the active ingredient in party drugs such as "ecstasy" or "molly" — to treat post-traumatic stress disorder (PTSD).
They will also be allowed to prescribe psilocybin, a compound found in psychotropic "magic" mushrooms, for treatment-resistant depression.
The TGA said the decision addressed the "lack of options" for people with some mental illnesses that did not respond to other treatments.
www.abc.net.au
International studies looking at psychedelics' ability to treat mental health conditions have shown promising results, however experts have urged caution and called for more research into their long-term effects before making them a mainstream treatment.
From July 1, authorised psychiatrists will be allowed to prescribe MDMA — the active ingredient in party drugs such as "ecstasy" or "molly" — to treat post-traumatic stress disorder (PTSD).
They will also be allowed to prescribe psilocybin, a compound found in psychotropic "magic" mushrooms, for treatment-resistant depression.
The TGA said the decision addressed the "lack of options" for people with some mental illnesses that did not respond to other treatments.
TGA approves psilocybin and MDMA for use in treating depression and PTSD
Australia's medical regulator has approved the use of psychedelics to treat some mental health conditions, making the country one of the first in the world to "officially recognise MDMA and psilocybin as medicines".
www.abc.net.au
